アリゾナ州における悪性黒色腫の臨床試験
アリゾナ州内の拠点で、悪性黒色腫に関する26件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- HonorHealth Research Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07751042Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Ironwood Cancer & Research Centers, Chandler
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Pan-tumor MRD Study
- Mohtaseb Cancer Center and Blood Disorders, Bullhead City
- Cancer & Blood Specialists of Arizona, Casa Grande
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中第3相
75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
被験者募集中第1/2相
18歳〜99歳 · 全性別 · 2026/09/22更新 · NCT06814496ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Ironwood Cancer & Research Centers, Chandler
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
- Banner MD Anderson Cancer Center, Gilbert
- Arizona State University-Honor Health Research Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07288112Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Arizona, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07287917A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Mayo Clinic Arizona, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Kingman Regional Medical Center, Kingman
- Banner Children's at Desert, Mesa
- Phoenix Childrens Hospital, Phoenix
- 他1件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
- HonorHealth Research Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/14更新 · NCT06425926Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Mayo Clinic Scottsdale - PPDS, Scottsdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/06更新 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- HonorHealth Research Insisute, Scottsdale
被験者募集中第2/3相
全年齢 · 全性別 · 2026/04/02更新 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Mayo Clinic Arizona, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/02/25更新 · NCT05549297Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Mayo Clinic Hospital, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2025/12/17更新 · NCT03567889A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- HonorHealth Research and Innovation Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/10/29更新 · NCT06249048SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Phoenix, Phoenix
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/25更新 · NCT05824975Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- HonorHealth Research Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- HonorHealth Research Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2024/02/08更新 · NCT04282044ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。